Article Text

Download PDFPDF
Fetal cardiac screening: why bother?
  1. G Sharland
  1. Department of Congenital Heart Disease, Evelina Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  1. Correspondence to Dr G Sharland, Fetal Cardiology Unit, 1st Floor, Evelina Children’s Hospital, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UK; gurleen.sharland{at}


Congenital heart disease (CHD) is a common form of congenital malformation associated with significant morbidity and mortality. Antenatal diagnosis of life-threatening forms of CHD may help to improve survival and morbidity as well as allowing parental choice and preparation. The diagnosis of CHD during fetal life can be made with a very high level of diagnostic accuracy in tertiary centres dealing with high-risk pregnancies. However, most cases of CHD will occur in low-risk groups and will only be detected by screening at the time of obstetric ultrasound scans. The concept of antenatal screening for CHD was introduced in the UK over 20 years ago, and current national guidelines recommend that the heart should be examined at the time of the obstetric anomaly scan. However, there remains a large regional variation in prenatal detection rates of CHD. Widespread teaching and training is required to achieve a more uniform standard but this will be associated with significant resource implications.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.